(Short AI summary)…….Immutep will present survival results for its cancer drug efti at two conferences:
* 19 November: soft tissue sarcoma trial.
* 14 December: final survival results from a head and neck cancer trial.
https://www.listcorp.com/asx/imm/immutep-limited/news/upcoming-poster-presentations-at-ctos-and-esmo-io-2026-3432936.html
Neil47
преди 2 месеца
Split
Well that sucks, looks like this is truly dead 🤔 barring a miracle.
Bigmike79
преди 2 месеца
Big movment
Looks positive today boys 👀 been holding for a loooooong time
I have been in this stock before and im thinking bout buying it again. Can you guys tell your perspective. When you expect a big move. If you ask me this stock should be $3.
Bigmike79
преди 6 месеца
News on the horizon
Bigmike79
преди 6 месеца
Whos here
Can see big potential in this who’s holding long term ?
Millerq3
преди 7 месеца
Immutep Announces Standard Bid‑Price Deficiency Notice
Nasdaq has sent Immutep the usual minimum bid‑price deficiency notice after the share price closed below \$1 for 30 consecutive trading days. This is an administrative step and doesn’t affect day‑to‑day operations, trading, or the company’s listing at this stage.
Immutep now has a 180‑day compliance window to regain the \$1 bid price. Companies in this situation typically resolve it through market movement, corporate actions, or by qualifying for an additional extension period if needed. The filing doesn’t indicate any immediate risk or change to the business.
Just sharing the update for anyone tracking the regulatory side.
https://www.sec.gov/Archives/edgar/data/1506184/000119312526198639/d131189dex991.htm
RKZ
преди 7 месеца
What’s going on?
This stock seems to go up to 60s each opening day and by closing it’s goes low 50s again
Riki0
преди 7 месеца
No shorters anymore
Think of it that way we don’t get shorters anymore now real investors are the ones coming in 😃
Riki0
преди 7 месеца
How are you people?
To all my holders from yesterday we are here let’s do it again
jbf072
преди 7 месеца
I feel good
So good
Du du du duuuuu
Fatig
преди 7 месеца
Pullback
Probably immp is trying to make a pull back since bird was the top runner most dudes left this stock be
Millerq3
преди 7 месеца
Immutep: Orphan Drug Win Backed by Fresh Insider Ownership Filings
На тази страница може да видиш съдържание, генерирано от клиентите, за което Trading 212 не носи отговорност. Винаги прави собствени проучвания. Trading 212 предоставя единствено услуга за изпълнение и не предлага инвестиционен съвет или управление на портфолиото.
Инвестирай в готови пайове или създай свой собствен, като избираш от хиляди акции и ETF-и
Научи повече
Научи повече
Гледай видеото
Така можеш да притежаваш дял дори от най-скъпите акции като Google, Amazon и Apple
Гледай видеото
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisbon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisbon
Виж всички инструменти за търговия
Поддръжка 24/7
Отговаряме в чата средно за 29 секунди
Започни да търгуваш сега
Присъедини се към над 5 милиона потребители
Изтегли приложението
Отвори сметка
Инсталирай мобилното приложение
Стойностите са глобални. Броят клиенти включва само тези със захранени сметки.
Отлично
Оценка 4,6/5 въз основа на 108 659 отзива в
Trustpilot
Оценка 4,6/5 въз основа на 108 659 отзива в
Trustpilot
Поканен
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Поканен
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Поканен
Reliable
Reliable, Secure. Using it for past 3 years
Поканен
An easy platform to use
An easy platform to use. Builds confidence in the safety of your money
Поканен
Brilliant
Brilliant! The app is great for keeping track of your investments
Поканен
I love seeing my interest go in daily
I love seeing my interest go in daily, I like the growth chart and like the look of the app overall.
Fairly easy to use.
Поканен
Great App
Great App. Keeps me informed of interest on a dailt basis.
Very good interest rate.
Thanks
Поканен
Easy to set up and app easy to navigate…
Easy to set up and app easy to navigate with to get updates on your account. Good interest rate on ISAs
Поканен
Excellent
Excellent! I use the community pie and ai, feature. Very good interface and easy to use.
Поканен
Such an easy app to navigate
Such an easy app to navigate. Opens up a world of investments and simplifies.
Поканен
Easy to use
It’s easy to use and good to see daily progress in your account
Поканен
Excellent service
Excellent service
Easy to use
Great platform
Safe and secure
Поканен
Great site
Great site, always sending me info of whats happening with my stocks. Love it.
Поканен
Cash isa
Easy to use app and easy to set up an account.
Поканен
T212 has created a very flexible…
T212 has created a very flexible platform that is easy to use for retail investors. The Cash ISA is brillant, and the Stocks ISA is very competive rather than holding a traditional account for individual stocks.
Поканен
Great app and investment tool
Great app, very easy to follow instruction and processes, great fee structure. Highly recommended for any retail investor looking to understand the market and get trading.
Поканен
Very easy to use
Very easy to use. I switched all my investment from different platform to trading 212
Поканен
Simple and easy to use!
Simple and easy to use app. Clear graphics and help if needed. Good interest rate.
Поканен
Daily interest addition is exciting
Daily interest addition is exciting. Excellent rates too!
Поканен
Love this site
Love this site, other platforms are like dinosaurs in comparison.
Great start to investing
Някои от положителните клиентски отзиви
Нашите награди
Често задавани въпроси
Каква е цената на акциите на Immutep?
Текущата цена на Immutep е 3,25 $.
Какъв е 52-седмичният максимум на Immutep?
52-седмичният максимум за Immutep е 70 $.
Какъв е 52-седмичният минимум на Immutep?
52-седмичният минимум за Immutep е 2,66 $.
Каква е седмичната ефективност на Immutep?
През изминалата седмица цената на Immutep се е променила с -8,71%.
Какво е месечната ефективност на Immutep?
През изминалия месец цената на Immutep се е променила с 1,56%.
Каква е 3-месечната ефективност на Immutep?
През последните три месеца цената на Immutep се е променила с -57,96%.
Каква е 6-месечната ефективност на Immutep?
През последните шест месеца цената на Immutep се е променила с -68,73%.
Каква е годишната ефективност на Immutep?
През изминалата година цената на Immutep се е променила с -91,22%.